Postal satiety, the signal that we're fooled, that's changing, and all of this together, these changes explain why just eat less and move more, becomes metabolically inefficient for many women midlife
The key question now is: Are GLP-1 agonists directly reducing inflammation by acting on the immune system
In ATTAIN-2 , which specifically studied people with both obesity and type 2 diabetes (a group for whom weight loss is known to be harder), participants on the highest dose lost an average of 10.5% of body weight (about 23 lbs) over 72 weeks, while also reducing A1C by an average of 1.8%
This personalized approach converts the question from 'Why is GLP-1 expensive?' to 'How do I choose the right GLP-1 for my genetic profile?' How Your Genetics Relate to GLP-1 Pathways Not everyone responds to GLP-1 medications the same way
In the context of GLP-1, this means having the ability to manage aseptic manufacturing at scale, ensure device compatibility, and execute rapid, reliable tech transfer
